A Duplication CNV That Conveys Traits Reciprocal to Metabolic Syndrome and Protects against Diet-Induced Obesity in Mice and Men
The functional contribution of CNV to human biology and disease pathophysiology has undergone limited exploration. Recent observations in humans indicate a tentative link between CNV and weight regulation. Smith-Magenis syndrome (SMS), manifesting obesity and hypercholesterolemia, results from a deletion CNV at 17p11.2, but is sometimes due to haploinsufficiency of a single gene, RAI1. The reciprocal duplication in 17p11.2 causes Potocki-Lupski syndrome (PTLS). We previously constructed mouse strains with a deletion, Df(11)17, or duplication, Dp(11)17, of the mouse genomic interval syntenic to the SMS/PTLS region. We demonstrate that Dp(11)17 is obesity-opposing; it conveys a highly penetrant, strain-independent phenotype of reduced weight, leaner body composition, lower TC/LDL, and increased insulin sensitivity that is not due to alteration in food intake or activity level. When fed with a high-fat diet, Dp(11)17/+ mice display much less weight gain and metabolic change than WT mice, demonstrating that the Dp(11)17 CNV protects against metabolic syndrome. Reciprocally, Df(11)17/+ mice with the deletion CNV have increased weight, higher fat content, decreased HDL, and reduced insulin sensitivity, manifesting a bona fide metabolic syndrome. These observations in the deficiency animal model are supported by human data from 76 SMS subjects. Further, studies on knockout/transgenic mice showed that the metabolic consequences of Dp(11)17 and Df(11)17 CNVs are not only due to dosage alterations of Rai1, the predominant dosage-sensitive gene for SMS and likely also PTLS. Our experiments in chromosome-engineered mouse CNV models for human genomic disorders demonstrate that a CNV can be causative for weight/metabolic phenotypes. Furthermore, we explored the biology underlying the contribution of CNV to the physiology of weight control and energy metabolism. The high penetrance, strain independence, and resistance to dietary influences associated with the CNVs in this study are features distinct from most SNP–associated metabolic traits and further highlight the potential importance of CNV in the etiology of both obesity and MetS as well as in the protection from these traits.
Vyšlo v časopise:
A Duplication CNV That Conveys Traits Reciprocal to Metabolic Syndrome and Protects against Diet-Induced Obesity in Mice and Men. PLoS Genet 8(5): e32767. doi:10.1371/journal.pgen.1002713
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002713
Souhrn
The functional contribution of CNV to human biology and disease pathophysiology has undergone limited exploration. Recent observations in humans indicate a tentative link between CNV and weight regulation. Smith-Magenis syndrome (SMS), manifesting obesity and hypercholesterolemia, results from a deletion CNV at 17p11.2, but is sometimes due to haploinsufficiency of a single gene, RAI1. The reciprocal duplication in 17p11.2 causes Potocki-Lupski syndrome (PTLS). We previously constructed mouse strains with a deletion, Df(11)17, or duplication, Dp(11)17, of the mouse genomic interval syntenic to the SMS/PTLS region. We demonstrate that Dp(11)17 is obesity-opposing; it conveys a highly penetrant, strain-independent phenotype of reduced weight, leaner body composition, lower TC/LDL, and increased insulin sensitivity that is not due to alteration in food intake or activity level. When fed with a high-fat diet, Dp(11)17/+ mice display much less weight gain and metabolic change than WT mice, demonstrating that the Dp(11)17 CNV protects against metabolic syndrome. Reciprocally, Df(11)17/+ mice with the deletion CNV have increased weight, higher fat content, decreased HDL, and reduced insulin sensitivity, manifesting a bona fide metabolic syndrome. These observations in the deficiency animal model are supported by human data from 76 SMS subjects. Further, studies on knockout/transgenic mice showed that the metabolic consequences of Dp(11)17 and Df(11)17 CNVs are not only due to dosage alterations of Rai1, the predominant dosage-sensitive gene for SMS and likely also PTLS. Our experiments in chromosome-engineered mouse CNV models for human genomic disorders demonstrate that a CNV can be causative for weight/metabolic phenotypes. Furthermore, we explored the biology underlying the contribution of CNV to the physiology of weight control and energy metabolism. The high penetrance, strain independence, and resistance to dietary influences associated with the CNVs in this study are features distinct from most SNP–associated metabolic traits and further highlight the potential importance of CNV in the etiology of both obesity and MetS as well as in the protection from these traits.
Zdroje
1. StankiewiczPLupskiJR 2010 Structural variation in the human genome and its role in disease. Annu Rev Med 61 437 455
2. ZhangFGuWHurlesMELupskiJR 2009 Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet 10 451 481
3. HorevGEllegoodJLerchJPSonYEMuthuswamyL 2011 Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism. Proc Natl Acad Sci U S A 108 17076 17081
4. LeeYS 2009 The role of genes in the current obesity epidemic. Ann Acad Med Singapore 38 45 43
5. CornierMADabeleaDHernandezTLLindstromRCSteigAJ 2008 The metabolic syndrome. Endocr Rev 29 777 822
6. HebebrandJVolckmarALKnollNHinneyA 2010 Chipping away the ‘missing heritability’: GIANT steps forward in the molecular elucidation of obesity - but still lots to go. Obes Facts 3 294 303
7. SpeliotesEKWillerCJBerndtSIMondaKLThorleifssonG 2010 Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42 937 948
8. WillerCJSpeliotesEKLoosRJLiSLindgrenCM 2009 Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41 25 34
9. JacquemontSReymondAZuffereyFHarewoodLWaltersRG 2011 Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 478 97 102
10. WaltersRGJacquemontSValsesiaAde SmithAJMartinetD 2010 A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 463 671 675
11. HawnJRiceCNicholsHMcDermottS 2009 Overweight and obesity among children with Down syndrome: a descriptive study of children attending a Down syndrome clinic in South Carolina. J S C Med Assoc 105 64 68
12. ButlerMG 2011 Prader-Willi Syndrome: Obesity due to Genomic Imprinting. Curr Genomics 12 204 215
13. PotockiLBiWTreadwell-DeeringDCarvalhoCMEifertA 2007 Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am J Hum Genet 80 633 649
14. PotockiLChenKSParkSSOsterholmDEWithersMA 2000 Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet 24 84 87
15. BiWLupskiJR 2008 RAI1, the Smith–Magenis, and Potocki–Lupski Syndromes. EpsteinCJEricksonRPWynshaw-BorisA Inborn Errors of Development 1078 1088
16. EdelmanEAGirirajanSFinucaneBPatelPILupskiJR 2007 Gender, genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of 105 cases. Clin Genet 71 540 550
17. ElseaSHGirirajanS 2008 Smith-Magenis syndrome. Eur J Hum Genet 16 412 421
18. BurnsBSchmidtKWilliamsSRKimSGirirajanS 2010 Rai1 haploinsufficiency causes reduced Bdnf expression resulting in hyperphagia, obesity and altered fat distribution in mice and humans with no evidence of metabolic syndrome. Hum Mol Genet 19 4026 4042
19. SmithACGropmanALBailey-WilsonJEGoker-AlpanOElseaSH 2002 Hypercholesterolemia in children with Smith-Magenis syndrome: del (17) (p11.2p11.2). Genet Med 4 118 125
20. WalzKCaratini-RiveraSBiWFonsecaPMansouriDL 2003 Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance. Mol Cell Biol 23 3646 3655
21. YanJBiWLupskiJR 2007 Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike. Am J Hum Genet 80 518 525
22. YanJKeenerVWBiWWalzKBradleyA 2004 Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome. Hum Mol Genet 13 2613 2624
23. WalzKSpencerCKaasikKLeeCCLupskiJR 2004 Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2). Hum Mol Genet 13 367 378
24. MolinaJCarmona-MoraPChrastJKrallPMCanalesCP 2008 Abnormal social behaviors and altered gene expression rates in a mouse model for Potocki-Lupski syndrome. Hum Mol Genet 17 2486 2495
25. RicardGMolinaJChrastJGuWGheldofN 2010 Phenotypic consequences of copy number variation: insights from Smith-Magenis and Potocki-Lupski syndrome mouse models. PLoS Biol 8 e1000543 doi:10.1371/journal.pbio.1000543
26. WalzKPaylorRYanJBiWLupskiJR 2006 Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2). J Clin Invest 116 3035 3041
27. BochukovaEGHuangNKeoghJHenningEPurmannC 2010 Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 463 666 670
28. ChoquetHMeyreD 2011 Molecular basis of obesity: current status and future prospects. Curr Genomics 12 154 168
29. BlakemoreAIFroguelP 2010 Investigation of Mendelian forms of obesity holds out the prospect of personalized medicine. Ann N Y Acad Sci 1214 180 189
30. SavageDB 2009 Mouse models of inherited lipodystrophy. Dis Model Mech 2 554 562
31. KlempelMCVaradyKA 2011 Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans. Nutr Rev 69 145 154
32. KadowakiTYamauchiTKubotaNHaraKUekiK 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116 1784 1792
33. ZingarettiMCCrostaFVitaliAGuerrieriMFrontiniA 2009 The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J 23 3113 3120
34. ZhangFPotockiLSampsonJBLiuPSanchez-ValleA 2010 Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS. Am J Hum Genet 86 462 470
35. GirirajanSPatelNSlagerRETokarzMEBucanM 2008 How much is too much? Phenotypic consequences of Rai1 overexpression in mice. Eur J Hum Genet 16 941 954
36. BiWOhyamaTNakamuraHYanJVisvanathanJ 2005 Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome. Hum Mol Genet 14 983 995
37. BiWYanJShiXYuva-PaylorLAAntalffyBA 2007 Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes. Hum Mol Genet 16 1802 1813
38. McCarthySEMakarovVKirovGAddingtonAMMcClellanJ 2009 Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 41 1223 1227
39. ShinawiMLiuPKangSHShenJBelmontJW 2010 Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 47 332 341
40. WeissLAShenYKornJMArkingDEMillerDT 2008 Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358 667 675
41. Brunetti-PierriNBergJSScagliaFBelmontJBacinoCA 2008 Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 40 1466 1471
42. ConsortiumIS 2008 Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 237 241
43. LupskiJR 2008 Schizophrenia: Incriminating genomic evidence. Nature 455 178 179
44. StefanssonHRujescuDCichonSPietiläinenOPIngasonA 2008 Large recurrent microdeletions associated with schizophrenia. Nature 455 232 236
45. CrespiBJ 2010 Revisiting Bleuler: relationship between autism and schizophrenia. Br J Psychiatry 196 495; author reply 495-496
46. CrespiBSummersKDorusS 2009 Genomic sister-disorders of neurodevelopment: an evolutionary approach. Evolutionary Applications 2 81 100
47. ShimanoHHortonJDHammerREShimomuraIBrownMS 1996 Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 98 1575 1584
48. TakahashiAShimanoHNakagawaYYamamotoTMotomuraK 2005 Transgenic mice overexpressing SREBP-1a under the control of the PEPCK promoter exhibit insulin resistance, but not diabetes. Biochim Biophys Acta 1740 427 433
49. ShimanoHShimomuraIHammerREHerzJGoldsteinJL 1997 Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest 100 2115 2124
50. Najafi-ShoushtariSHKristoFLiYShiodaTCohenDE 2010 MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328 1566 1569
51. RaynerKJSuárezYDávalosAParathathSFitzgeraldML 2010 MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328 1570 1573
52. BrownMSYeJGoldsteinJL 2010 Medicine. HDL miR-ed down by SREBP introns. Science 328 1495 1496
53. SchmickelRD 1986 Clinical genetics conference: progress in understanding muscle disease. J Pediatr 109 1071 1073
54. LupskiJR 1998 Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet 14 417 422
55. LupskiJR 2009 Genomic disorders ten years on. Genome Med 1 42
56. LupskiJRBelmontJWBoerwinkleEGibbsRA 2011 Clan genomics and the complex architecture of human disease. Cell 147 32 43
57. LupskiJRStankiewiczP 2005 Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet 1 e49 doi:10.1371/journal.pgen.0010049
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 5
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice
- Genome-Wide Association of Pericardial Fat Identifies a Unique Locus for Ectopic Fat
- Slowing Replication in Preparation for Reduction
- Deletion of PTH Rescues Skeletal Abnormalities and High Osteopontin Levels in Mice